SERUM FATTY ACIDS IN MULTIPLE SCLEROSIS - PubMed (original) (raw)

SERUM FATTY ACIDS IN MULTIPLE SCLEROSIS

R W BAKER et al. J Neurol Neurosurg Psychiatry. 1964 Oct.

No abstract available

PubMed Disclaimer

Similar articles

• [CONTRIBUTION TO THE STUDY OF PLASMATIC FATTY ACIDS IN ATHEROSCLEROTIC SUBJECTS. RESEARCH CONDUCTED WITH GAS-PHASE CHROMATOGRAPHY].
  LUNA G, D ARRIGO G, SAGLIMBENE F, TAMBURINO G. LUNA G, et al. Boll Soc Ital Biol Sper. 1963 Dec 31;39:1735-7. Boll Soc Ital Biol Sper. 1963. PMID: 14150788 Italian. No abstract available.
• Major plasma lipids and their fatty acid composition in multiple sclerosis and other neurological diseases.
  Karlsson I, Alling C, Svennerholm L. Karlsson I, et al. Acta Neurol Scand. 1971;47(4):403-12. doi: 10.1111/j.1600-0404.1971.tb07495.x. Acta Neurol Scand. 1971. PMID: 5123482 No abstract available.
• [Further studies on lipids and the spectra of fatty acids in the blood serum of patients with multiple sclerosis].
  Vymazal J, Tichý J. Vymazal J, et al. Cesk Neurol. 1972 Jul;35(4):195-201. Cesk Neurol. 1972. PMID: 5044148 Czech. No abstract available.
• THE FATTY ACID COMPOSITION OF HUMAN RETINAL VITAMIN A ESTER AND THE LIPIDS OF HUMAN RETINAL TISSUE.
  FUTTERMAN S, ANDREWS JS. FUTTERMAN S, et al. Invest Ophthalmol. 1964 Aug;3:441-4. Invest Ophthalmol. 1964. PMID: 14203336 No abstract available.
• LIVER LIPIDS IN A CASE OF HYPERVITAMINOSIS A.
  Krause RF. Krause RF. Am J Clin Nutr. 1965 Jun;16(6):455-7. doi: 10.1093/ajcn/16.6.455. Am J Clin Nutr. 1965. PMID: 14301352 No abstract available.

Cited by

• Linoleate and fatty-acid patterns of serum lipids in multiple sclerosis and other diseases.
  Love WC, Cashell A, Reynolds M, Callaghan N. Love WC, et al. Br Med J. 1974 Jul 6;3(5922):18-21. doi: 10.1136/bmj.3.5922.18. Br Med J. 1974. PMID: 4835464 Free PMC article.
• Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation.
  Cui G, Qin X, Wu L, Zhang Y, Sheng X, Yu Q, Sheng H, Xi B, Zhang JZ, Zang YQ. Cui G, et al. J Clin Invest. 2011 Feb;121(2):658-70. doi: 10.1172/JCI42974. Epub 2011 Jan 25. J Clin Invest. 2011. PMID: 21266776 Free PMC article.
• A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis.
  Bates D, Cartlidge NE, French JM, Jackson MJ, Nightingale S, Shaw DA, Smith S, Woo E, Hawkins SA, Millar JH, et al. Bates D, et al. J Neurol Neurosurg Psychiatry. 1989 Jan;52(1):18-22. doi: 10.1136/jnnp.52.1.18. J Neurol Neurosurg Psychiatry. 1989. PMID: 2540285 Free PMC article. Clinical Trial.
• Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients.
  Hunter MI, Nlemadim BC, Davidson DL. Hunter MI, et al. Neurochem Res. 1985 Dec;10(12):1645-52. doi: 10.1007/BF00988606. Neurochem Res. 1985. PMID: 4088434
• Serial levels of plasma linoleic acid in tetanus.
  Callaghan N, Kearney B, Love WC. Callaghan N, et al. Ir J Med Sci. 1976 Dec;145(1):243. doi: 10.1007/BF02938954. Ir J Med Sci. 1976. PMID: 27517238

References

1. 1. Lancet. 1956 Apr 7;270(6919):381-3 - PubMed
2. 1. J Clin Invest. 1957 Feb;36(2):233-44 - PubMed
3. 1. Am J Med Sci. 1950 Oct;220(4):421-30 - PubMed
4. 1. J Clin Invest. 1959 Sep;38:1544-54 - PubMed
5. 1. J Neurochem. 1963 Dec;10:889-902 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • HighWire
  • PubMed Central